Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosuvastatin Augmentation of Post-Occlusive Reactive Hyperaemia and Adenosine-Receptor Mediation
2008-005985-30Phase 4Active
- Sponsor
- Department of Pharmacology and Toxicology
- Start
- Sep 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of rosuvastatin in hypoxia, sponsored by Department of Pharmacology and Toxicology. Primary endpoints: Forearm blood flow after 3 minutes ischemia, Forearm blood flow after 5 minutes ischemia and 1 more. Started Sep 2008; status: active.
02
Drugs
rosuvastatin
03
Conditions
hypoxia
Beyond the preview
Go deeper on 2008-005985-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005985-30.